<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">MRP</journal-id><journal-title-group><journal-title>Medical Research and Practice</journal-title></journal-title-group><issn>2993-9690</issn><eissn>2993-9704</eissn><publisher><publisher-name>Art and Technology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.61369/MRP.8036</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>桂芍知母汤调控cGAS-STING-NF-κB对CIA大鼠骨保护机制研究</title><url>https://artdesignp.com/journal/MRP/2/8/10.61369/MRP.8036</url><author>丁明辉,徐鹏刚</author><pub-date pub-type="publication-year"><year>2024</year></pub-date><volume>2</volume><issue>8</issue><history><date date-type="pub"><published-time>2024-08-20</published-time></date></history><abstract>目的：基于cGAS-STING-NF-&amp;kappa;B通路探讨桂枝芍药知母汤在控制胶原诱导性关节炎（CIA）大鼠炎症活动及起到骨保护作用的相关分子机制。 方法 Wistar大鼠60只，随机分为正常组、模型组、甲氨蝶呤组及桂芍知母汤低、中、高剂量组，每组10只，干预4 周，qPCR 法检测滑膜组织OPG、RNAK、RANKL mRNA 表达情况，ELISA法检测大鼠血清cGAMP、IL-6水平。结果 与正常组大鼠相比，模型组大鼠RANK、RANKL mRNA 表达上调，而OPG mRNA表达下降（P&amp;lt;0.05）， 各治疗组与模型组相比，OPG mRNA 表达升高，RANK、RANKL mRNA 表达有所下降（P&amp;lt;0.05）；桂芍知母汤大剂量组对OPG mRNA 上调较明显（P&amp;lt;0.05）；随着药物浓度逐渐增加，RANK、RANKLmRNA表达抑制进一步加强（P&amp;lt;0.05）。模型组血清cGAMP、IL-6水平较正常组升高（P&amp;lt;0.05）；各药物治疗组血清cGAMP、IL-6水平低于模型组，其中桂芍知母汤高剂量组改善尤为突出（P&amp;lt;0.05）。结论 桂枝芍药知母汤能调控cGAS-STING-NF&amp;kappa;B轴的相关细胞因子表达，从而缓解CIA大鼠关节炎症反应，并抑制RANK/RANKL 等骨破坏相关因子的表达，起到一定的骨保护作用。</abstract><keywords>类风湿关节炎 ,桂枝芍药知母汤 ,骨质破坏</keywords></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>[1]ZHANG Q, LENARDO M J, BALTIMORE D. 30 Years of NF-&amp;kappa;B: A Blossoming of Relevance to Human Pathobiology［J］．Cell (Cambridge), 2017,168(1-2): 37-57.[2]AGGARWAL B B. Nuclear factor-&amp;kappa;B: The enemy within［J］．Cancer Cell,2004,6(3): 203-208.[3] 李亦丞．基于NF-&amp;kappa;B 及OPG/RANKL/RANK信号通路探究青蒿琥酯对骨关节炎的作用及机制［D］．新疆医科大学，2020.[4] 丁明辉，曹茸，徐鹏刚，等．桂枝芍药知母汤抑制cGAS/STING/NF-&amp;kappa;B通路对类风湿关节炎大鼠炎症活动的影响［J］．现代中西医结合杂志，2024,33(08): 1053-1059.[5] 张仲景．金匮要略方论［M］．北京：人民卫生出版社，1956: 18-19.[6]李雪萍，刘伟伟，郑川，等．从&amp;ldquo;络病-风药&amp;rdquo;新识桂枝芍药知母汤治疗类风湿性关节炎［J］．时珍国医国药，2018(02): 391-393.[7]TANIGUCHI K, KARIN M. NF-&amp;kappa;B, inflammation, immunity and cancer: coming of age［J］．Nature Reviews Immunology, 2018,18(5): 309-324.[8]HOPFNER K, HORNUNG V. Molecular mechanisms and cellular functions of cGASSTING signalling［J］．Nature reviews. Molecular cell biology, 2020,21(9): 501-521.[9]CRONSTEIN B N, AUNE T M. Methotrexate and its mechanisms of action in inflammatory arthritis［J］．Nature reviews. Rheumatology, 2020,16(3): 145-154.[10]TRENKMANN M, BROCK M, BERTONCELJ M F, et al. Epigenetic Repression of the Long Noncoding Rna Hotair Regulates NF-KB Signalling and the Expression of Matrix Metalloproteases in Synovial Fibroblasts［J］．Annals of the Rheumatic Diseases, 2013,72(Suppl 3): A201.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
